Results 31 to 40 of about 27,891 (280)
Montelukast Inhibits Platelet Activation Induced by Plasma From COVID-19 Patients
Leukotrienes are important pro-inflammatory lipid mediators derived from the arachidonic acid metabolism. In particular, cysteinyl leukotrienes, namely LTC4, LTD4, and LTE4 are involved in many of the principal features of asthma, while more recently ...
M. Camera+3 more
semanticscholar +1 more source
Background The coronavirus disease 2019 (COVID-19) pandemic continues to affect the globe. After 18 months of the SARS-CoV-2 emergence, clinicians have clearly defined a subgroup of patients with lasting, disabling symptoms.
Francisco Mera-Cordero+10 more
semanticscholar +1 more source
Pediatric Asthma: Where Has Montelukast Gone?
At its introduction in the management of pediatric asthma, montelukast was regarded as a potentially revolutionary drug due to its mechanism of action and easy clinical applicability.
Marco Maglione+3 more
doaj +1 more source
Adverse Drug Reactions (ADRs) of Montelukast in Children
Montelukast is a leukotriene receptor antagonist (LTRA) commonly prescribed for asthma, allergic rhinitis and sleep-related breathing disorders. Recently, some studies have reported several adverse events, such as neuropsychiatric disorders and sleep ...
Abdullah Al-Shamrani+8 more
semanticscholar +1 more source
Montelukast: Chronic Urticaria [PDF]
This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or
Joyce A. Generali, Dennis J. Cada
openaire +3 more sources
Montelukast Inhibits HCoV-OC43 Infection as a Viral Inactivator
Coronaviruses (CoVs) consist of a large group of RNA viruses causing various diseases in humans and in lots of animals. Human coronavirus (HCoV) OC43, the prototype of beta-coronavirus discovered in the 1960s, has been circulating in humans for long time,
Yongkang Chen+3 more
semanticscholar +1 more source
Montelukast and Nightmares: Further Characterisation Using Data from VigiBase
Montelukast is a medicine indicated for use in asthma. Psychiatric disorders including nightmares have not been described in clinical trials but during recent years have been included in the product information as having been reported post-marketing ...
Sarah Watson+4 more
semanticscholar +1 more source
Tailored second line therapy in asthmatic children with the arginine-16 genotype [PDF]
The arginine-16 beta-2 receptor genotype confers increased susceptibility to exacerbations in asthmatic children taking regular long acting beta-2 agonists.
Aziz+27 more
core +1 more source
The inflammatory/anti‐inflammatory balance has an important role in the clinical course of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) (coronavirus disease [COVID‐19]) infection, which has affected over 200 million people since it first ...
Buğra Kerget+3 more
semanticscholar +1 more source
Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma [PDF]
Asthma patients who continue to experience symptoms despite being on regular inhaled corticosteroids (ICS) represent a management challenge. Long-acting beta2-agonists (LABA) or anti-leukotrienes (LTRA) are two treatment options that could be considered ...
Adams+207 more
core +1 more source